Literature DB >> 1655065

Cytochemically unreactive neutrophils from subjects with myeloperoxidase (MPO) deficiency show a complex pattern of immunoreactivity with anti-MPO monoclonal antibodies: a flow cytometric and immunocytochemical study.

F Lanza1, A Latorraca, P Musto, L Ferrari, S Moretti, G Zabucchi, M Carotenuto, G L Castoldi.   

Abstract

Neutrophil granulocytes from 12 subjects with primary myeloperoxidase (MPO) deficiency (six totally deficient) and 16 patients with secondary partial MPO deficiency were tested using two different anti-MPO antibodies, in combination with either a flow-cytometric technique or an immunoalkaline phosphatase staining method. Results demonstrated three different cytofluorimetric patterns of immunoreactivity with the MPO protein: (a) a bright MPO antigenic expression, typical of patients with secondary MPO deficiency (comparable to that observed in the control group); (b) a medium MPO antigenic expression, typical of subjects with primary partial MPO deficiency; and (c) a dim MPO antigenic expression, characteristic of individuals with hereditary total MPO deficiency. No significant differences in granulocyte MPO reactivity were demonstrated for the two antibodies. Furthermore, in two individuals with complete primary enzyme deficiency, the single histogram analysis of MPO fluorescence determined by flow cytometry seemed to show that only 38% (case 1) and 44% (case 2) of neutrophils were reactive with the anti-MPO antibodies: the use of multiple histogram analysis in combination with Kolmogorov-Smirnov statistics allowed us to demonstrated that all the cells express a low density of MPO antigen. These data were more or less confirmed by the APAAP labeling method, which showed a reduced straining only in subjects with primary deficiency, while all patients with secondary deficiency had scores similar to those observed in controls (healthy subjects). Compared with the immunoenzymatic technique, the flow-cytometric procedure showed a higher sensitivity to MPO, being able to estimate even minor decreases in neutrophil MPO antigenic expression, as previously postulated by other authors. This work suggests that patients with primary MPO deficiency have different amounts of MPO antigens in the neutrophil granulocytes, and the levels of MPO fluorescence seem to decline concurrently with the enzyme activity, thereby suggesting the presence of a diminished MPO production. In contrast, the normal antigenic reactivity of neutrophils from patients with acquired MPO deficiency indicates the presence of a functionally inactive form of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655065     DOI: 10.1007/bf01707280

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  37 in total

1.  Posttranslational processing of a human myeloid lysosomal protein, myeloperoxidase.

Authors:  W M Nauseef
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

2.  Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells.

Authors:  L G Larsson; M Schena; M Carlsson; J Sällström; K Nilsson
Journal:  Blood       Date:  1991-03-01       Impact factor: 22.113

3.  Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources.

Authors:  I T Young
Journal:  J Histochem Cytochem       Date:  1977-07       Impact factor: 2.479

4.  Eosinophil peroxidase deficiency detected by the Technicon H 1 system.

Authors:  F Lanza; G L Castoldi; M Masotti
Journal:  Blut       Date:  1988-03

5.  Separation and analysis of subcellular organelles in a human promyelocytic leukemia cell line, HL-60: application to the study of myeloid lysosomal enzyme synthesis and processing.

Authors:  W M Nauseef; R A Clark
Journal:  Blood       Date:  1986-08       Impact factor: 22.113

6.  Hereditary myeloperoxidase deficiency.

Authors:  P Cech; A Papathanassiou; G Boreux; P Roth; P A Miescher
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

7.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

8.  Recommended methods for cytological procedures in haematology. International Committee for Standardization in Haematology (ICSH).

Authors:  A Shibata; J M Bennett; G L Castoldi; D Catovsky; G Flandrin; E S Jaffe; I Katayama; K Nanba; F Schmalzl; L T Yam
Journal:  Clin Lab Haematol       Date:  1985

9.  [The Alius-Grignaschi anomaly: the hereditary constitutional peroxidase defect of the neutrophils and monocytes].

Authors:  E Undritz
Journal:  Blut       Date:  1966-12

10.  Human myeloperoxidase gene: molecular cloning and expression in leukemic cells.

Authors:  K S Chang; J M Trujillo; R G Cook; S A Stass
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

View more
  1 in total

1.  Selective involvement of monocytes by acquired myeloperoxidase deficiency in a case of chronic myelomonocytic leukemia.

Authors:  A De Pasquale; L Ginaldi; G Di Leonardo; S Francavilla; D Quaglino
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.